Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial
- PMID: 38008160
- DOI: 10.1016/j.kint.2023.11.003
Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial
Keywords: IgA nephropathy; chronic kidney disease; complement; cytokines; glomerulus; proteinuria.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous